Der neueste Peer-reviewed Artikel


    Theranostics. 2019 Feb 20;9(5):1490-1509. doi: 10.7150/thno.29546.
    Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers.
    Goody D, Gupta SK, Engelmann D, Spitschak A, Marquardt S, Mikkat S, Meier C, Hauser C, Gundlach JP, Egberts JH, Martin H, Schumacher T, Trauzold A, Wolkenhauer O, Logotheti S, Pützer BM.

Der neueste Buchartikel


    Methods Mol Biol. 2019;1912:33-52. doi: 10.1007/978-1-4939-8982-9_2.
    p73-Governed miRNA Networks: Translating Bioinformatics Approaches to Therapeutic Solutions for Cancer Metastasis.
    Logotheti S, Marquardt S, Pützer BM.

Der neueste Abstract


    New Horizons in Translational Medicine Volume 4;1-4:48-98.
    E2F1 signaling promotes chemoresistance and lymphogenic metastasis in penile cancer revealing new prognostic biomarkers.
    Fenner F, Goody D, Protzel C, Erbersdobler A, Richter C, Hartz J, Naumann CM, Kalthoff H, Herchenröder O, Hakenberg OW, Pützer BM.

Die neueste Abschlussarbeit


    Juliane Marie Hartz (Ärztin)
    Analyse metastasierungsrelevanter microRNAs und deren prognostische Bedeutung für das Peniskarzinom
    Rostock 

... weitere Publikationen


    Theranostics 2018; 8(4):1106-1120.
    MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance.
    Lai X, Gupta SK, Schmitz U, Marquardt S, Knoll S, Spitschak A, Wolkenhauer O, Pützer BM, Vera J.
    Brain Struct Funct (2016) 221:2049–2059
    Novel subventricular zone early progenitor cell-specific adenovirus for in vivo therapy of central nervous system disorders reinforces brain stem cell heterogeneity.
    Reetz J, Hildebrandt S, Schmidt A, Meier C, Herchenröder O, Gläser A, Witt M, Pützer BM, Wree A.
    Gene Expression. 1999; 8:1-18.
    A multi-protein complex consisting of the cellular coactivator p300, AP-1/ATF as well as NF-kB is responsible for the activation of the mouse major histocompatibility class I (H-2Kb) enhancer A.
    Brockmann, Pützer BM, Lipinski KL, Schmücker U, Esche H